NASDAQ$ALHC

Alignment Healthcare Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

Reported financial results for the second quarter ended June 30, 2021.

Alignment Healthcare reported strong second-quarter results, exceeding expectations in membership, revenue, adjusted gross profit, and adjusted EBITDA, leading to an increased full-year outlook for 2021. The company made progress on its growth strategy by entering new states, expanding to contiguous markets, and developing new customer-focused plans, positioning it well for 2022.

  • Results in the second quarter exceeded expectations across the board including membership, revenue, adjusted gross profit and adjusted EBITDA.
  • Outlook for the full year of 2021 was raised.
  • Notable progress was made on growth strategy by entering new states, expanding to contiguous markets, and developing new, innovative customer-focused plans.
  • Provider network was expanded to support growth in new markets by signing several partnerships with high-quality providers.

Headline financials

Total Revenue

$309M

Previous: $244M+26.5%
EPS (adj)

-$0.25

Previous: $0.05-554.6%
Free Cash Flow

-$44.8M

No prior period
Net Income

-$44.8M

Previous: $8.37M-635.1%
Operating Income

-$40.5M

Previous: $12.6M-421.7%
Gross Profit

$309M

Previous: $49.8M+520.2%
Cash & Equivalents

$495M

No prior period
Total Assets

$670M

No prior period

Revenue & EPS history

Alignment Healthcare · Revenue · Quarterly

$309M

Q2 2021+26.5%vs Q2 2020
Beat estimate in 12 of 12 quarters(100%)
ActualEstimate

Revenue by segment

Alignment Healthcare · $265M total across 2 segments · Q1 2021

  • Earned premiums
    $265M+18.0%
  • Other revenue
    $82K

Forward guidance

The release contains forward-looking statements regarding future growth and financial outlook for the third quarter ended September 30, 2021 and year ended December 31, 2021.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

+1.8%

Avg return

Earnings day

+1.8%

Avg return

5 days after

+2.6%

Avg return

30 days after

57%

12 / 21 earnings

Positive

+27.0%

Q1 2024

Best reaction

-16.4%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.8%-15.7%-29.5%
Q4 2025-5.8%-7.5%-18.6%
Q3 2025-1.9%-0.4%+12.2%
Q1 2025-7.7%-7.5%-8.3%
Q4 2024+16.5%+17.4%+35.9%
Q3 2024+1.6%+12.2%+11.2%
Q2 2024+2.3%+4.9%+3.1%
Q1 2024+27.0%+31.6%+51.0%
Q4 2023-8.9%-9.2%-20.1%
Q3 2023-9.6%-7.2%+10.5%
Q2 2023+7.5%+10.5%-4.2%
Q1 2023+3.5%+11.3%-5.1%
Q4 2022-16.4%-20.9%-35.2%
Q3 2022-3.1%-3.3%-2.7%
Q2 2022+10.4%+4.3%-8.7%
Q1 2022-7.0%-18.8%+6.8%
Q4 2021+10.7%+8.0%+39.7%
Q3 2021+10.6%+6.1%-26.7%
Q2 2021-8.5%-4.8%-11.2%
Q1 2021+6.8%+13.3%+27.6%
Q4 2020+6.8%+13.3%+27.6%
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro